How hospice became big business. A new investigation in The New Yorker reveals an industry that at times puts profits before patients.
Guest Host: Susan Page
A panel of experts discusses likely short-term risks and rewards inherent in the advances made possible by the mapping of the human genome.
- Dr. William Hazeltine Human Genome Sciences, Inc.
- Andrew Kimbrell International Center for Technology Assessment
- Dr. Robert Waterson Director of the Genome Sequencing Center and head of the department of genetics at Washington University School of Medicine
Most Recent Shows
Pulitzer Prize-winning biographer Jon Meacham on the evolution of Abraham Lincoln's moral principles and political leadership -- and what the era of Lincoln can teach us about the state of our democracy today.
What troubles at Twitter say about the state of social media -- and why one tech watcher argues this could transform the industry in positive ways.
Political analyst Norman Ornstein on control of Congress, the red wave that wasn't, and other lessons from the midterm elections.